http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106866684-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106866684-B |
| titleOfInvention | Macrocyclic derivatives for the treatment of tumors |
| abstract | The invention discloses a compound which can regulate the activity of protein kinase and is used for treating or preventing diseases related to the protein kinase. Specifically, the invention relates to a macrocyclic derivative for treating tumors, belongs to a compound for regulating the activity of Anaplastic Lymphoma Kinase (ALK), and provides a preparation method of the compound and pharmaceutical application of the compound in treating or preventing ALK-related diseases. |
| priorityDate | 2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.